Following a flood of investment into the Treg directed therapies space, the hotly anticipated Treg Directed Therapies Summit is the only event gathering the key decision-makers in this fast-developing field.
Our attendees, the movers and shakers in this field, are seeking solutions to optimize Treg expansion, characterize stability, and streamline clinical development.
This is your unmissable opportunity to establish long-term partnerships and secure new business as the cell therapy space turns its focus to this next generation. Discover more in our full event guide.
Join the conversation with C-Level Executives, VPs, and Directors to establish yourself as the industry partner of choice who can:
- Progress cell phenotyping to assess stability and function
- Advance cell engineering to achieve antigen-specific targeting
- Optimize large-scale clinical trial development to prove efficacy in autoimmunity, transplant, and inflammatory conditions
Generate new business leads by securing invaluable connections with key decision-makers through structured networking and preorganized 1-2-1 meetings
Build your network with the key decision-makers and pioneers in this fast-developing field, to form long-lasting business relationships as the industry takes new heights
Showcase your capabilities by positioning your product to C-Suite Executives, Vice Presidents & Directors at both Big Pharma companies and the innovative biotechs leading the way in cell therapy development
Share your insights and thought leadership to help drug developers overcome preclinical and clinical challenges to progress Treg modulated therapies to address unmet need